BREAKING NEWS: VIMIAN GROUP ROARS INTO NASDAQ MAIN MARKET!
STOCKHOLM, 28 MARCH 2025 – Hold onto your hats, because Vimian Group AB (that’s ticker VIMIAN for the finance geeks out there) is officially making a splash on the Nasdaq Stockholm Main Market starting TODAY! Can you feel the excitement? This ambitious move marks Vimian’s ascent from the Nasdaq First North Growth Market, where it first landed in June 2021.
But wait – there’s more! Vimian becomes the 11th company this year to join Nasdaq’s Nordic and Baltic markets, making history! This isn’t just any transfer; it’s the 141st leap from First North to the big leagues of Nasdaq Main Markets in the Nordics.
What is Vimian, you ask? Let’s break it down: This powerhouse is a trailblazer in global animal health, specializing in four explosive sectors: Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. With a bold mission of making cutting-edge health solutions available to over 17,000 veterinary clinics and laboratories worldwide, they’re unleashing innovative products like never before!
Patrik Eriksson, the fearless CEO of Vimian, stated, "Today marks an important milestone for Vimian as we start trading on Nasdaq’s Main Market. Our strong and profitable growth history keeps us at the forefront of the global animal health scene, and we’re just getting warmed up!"
And let’s hear it for Nasdaq’s Head of European Listings, Adam Kostyál, who added, "We couldn’t be more thrilled to welcome Vimian Group to our Main Market! This is no small feat—a testament to their relentless pursuit of growth since their first listing in 2021. They’re about to reach new heights, gaining access to a parade of global investors!"
Get ready, world! Vimian Group is set to amplify its visibility and forge ahead in the animal health realm. Buckle up for this exciting journey as they accelerate toward even greater success!
This is one blockbuster story you won’t want to miss!
